Company · London
Selective Supplies Limited
Wholesale of pharmaceutical goods
Official record Companies House · updated 27th September 2026 · Sources
Network
The large node is Selective Supplies Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 5
- Bharat Kumar Hansraj Devraj Shah 2022-2025 View profile
- Phillip Huw Thomas 2000-2022 View profile
- Janette Denise Thomas 2003-2022 View profile
- Steven Edward Delaney 1999-2007 View profile
- Mitzi Sharon Cutler 1999-2001 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
Public contracts won
7 contracts · £15,529,352 totalFrom Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.
-
NHS National Generic Pharmaceuticals - Wave 16a
NHS National Framework for Generics Pharmaceuticals Wave 16a Offer reference number: CM/PHG/24/5714 Period of framework agreement: Dates detailed below, with an option or options to extend (at the authority’s discretion) for a period or per…
Framework -
Anti-Infective Drugs 3
Generic Anti-Infective Drugs
-
Oncology Generics Medicines
This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in secti…
Framework -
NHS National Generic Pharmaceuticals Interim 2 2020
Hospital only products - All regions:01/02/2021 to 31/01/2022Orals (plus non-parenterals) – Allregions: 01/03/2021 to 28/02/202212 months with an option or options toextend (at the Authority’s discretion) fora period or periods up to a tota…
Framework -
NP36126 Antibiotic & Genito Urinary Medicines
Supply of Antibiotic & Genito Urinary Medicines to NHS Scotland.
Framework -
NHS National Branded Interim - 1 June 2026
Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months
Framework -
NHS National Generics Pharmaceuticals - Supply Chain Resilience
NHS National Generics Pharmaceuticals - Supply Chain Resilience Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months…
Framework
About
- What it does
- Wholesale of pharmaceutical goods
- Incorporated
- 23/06/1999
- Registered office
- London
Ownership
Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.
- Sigma Pharmaceuticals PLC
75-100% shares, 75-100% voting · notified 2022-03-31
Group
- Selective Supplies Limited
is controlled by Sigma Pharmaceuticals PLC
Evidence
active 75-100% shares, 75-100% voting · notified 2022-03-31 · source: Companies House PSC register - Sigma Pharmaceuticals PLC
is controlled by Orion Holdings (UK) Limited
Evidence
active 75-100% shares, 75-100% voting, appoints directors · notified 2016-04-06 · source: Companies House PSC register
Ultimately controlled by Orion Holdings (UK) Limited.
20 other companies in this group
- Delta Pharma (Europe) Limited
- Carter (2005) Property Limited
- OPD Laboratories Limited
- Clarepharm Limited
- Modern Pharma Limited
- TSU (Europe) Limited
- Smartspruce Limited
- Sigma Properties Limited
- BMK Properties Limited
- Carter Chemist Limited
- H D Dental Limited
- 08980191
- Sigcare Limited
- Carter Chemist (2005) Limited
- RX Farma Limited
- Special Concept Development (UK) Limited
- Sigma Pharmaceuticals PLC
- 09140968
- Pharma - XL LTD
- Orion Holdings (UK) Limited
Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
6 directors on the board
- Bhavin Manish Shah Director · appointed 2025
- Mark Richard Hampton Director · appointed 2025
- Hatul Bharat Kumar Shah Director · appointed 2025
- James Marcus Henry Moir Director · appointed 2025
- Rajiv Bharat Kumar Shah Director · appointed 2025
- Rajesh Shantilal Haria Director · appointed 2022
First-time vs portfolio directors
Portfolio (6)
- Bhavin Manish Shah Director · appointed 2025
- Mark Richard Hampton Director · appointed 2025
- Hatul Bharat Kumar Shah Director · appointed 2025
- James Marcus Henry Moir Director · appointed 2025
- Rajiv Bharat Kumar Shah Director · appointed 2025
- Rajesh Shantilal Haria Director · appointed 2022
Also govern a charity
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 03794482
- Status
- Active
- Type
- Private Limited Company
- Accounts next due
- 31/05/2027
- Edition
- Register edition compiled 27th September 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data